(BBUS) JPMorgan BetaBuilders U.S. - Overview
Etf: Stocks, Large-Cap, Mid-Cap
Dividends
| Dividend Yield | 1.15% |
| Yield on Cost 5y | 1.96% |
| Yield CAGR 5y | 8.51% |
| Payout Consistency | 99.1% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.4% |
| Relative Tail Risk | 5.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.61 |
| Alpha | -0.27 |
| Character TTM | |
|---|---|
| Beta | 0.963 |
| Beta Downside | 0.971 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.01% |
| CAGR/Max DD | 1.11 |
Description: BBUS JPMorgan BetaBuilders U.S. January 09, 2026
The JPMorgan BetaBuilders U.S. Equity ETF (BBUS) tracks a free-float-adjusted, market-cap-weighted index that captures roughly the top 85 % of U.S. equities by market value, focusing on large- and mid-cap stocks. The fund is required to hold at least 80 % of its assets in the index constituents, delivering broad exposure to the U.S. equity market while maintaining a “large-blend” profile.
As of the latest filing, BBUS carries an expense ratio of 0.10 % and manages about $1.2 billion in assets, with a low turnover rate near 5 %-indicating a relatively passive, cost-efficient structure. The top sector allocations are roughly 25 % technology, 15 % healthcare, and 13 % financials, reflecting the current macro-driven drivers of U.S. corporate earnings such as Fed policy, consumer spending trends, and the ongoing digital transformation. The ETF’s beta to the S&P 500 hovers around 1.0, suggesting it moves in step with the broader market while offering modest diversification benefits.
If you want a deeper, data-rich look at BBUS’s risk-adjusted performance and factor exposures, ValueRay provides a free analytics dashboard that can help you validate whether the fund fits your investment thesis.
What is the price of BBUS shares?
Over the past week, the price has changed by -0.26%, over one month by -0.49%, over three months by +2.88% and over the past year by +14.63%.
Is BBUS a buy, sell or hold?
What are the forecasts/targets for the BBUS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 146.5 | 17.7% |
BBUS Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 7.11b USD (7.11b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 7.11b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 7.11b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.46% (E(7.11b)/V(7.11b) * Re(9.46%) + (debt-free company))
Discount Rate = 9.46% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)